INBICON A/S: Financial statements 2015
CVR: 27036635
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
INBICON A/S (CVR 27036635) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -43,216,000 and a net result of DKK -35,128,000 compared with DKK -45,435,000 the year before. Equity in the 2015 report amounted to DKK 63,886,000. The solvency ratio was 70.3%.
- Gross Profit
- DKK -43,216,000
- Profit/Loss
- DKK -35,128,000
- Equity
- DKK 63,886,000
- Total Assets
- DKK 90,927,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -43.2 mio. | -35.1 mio. | 63.9 mio. | - |
| 2014 | 14 mio. | -61.4 mio. | -45.4 mio. | 59 mio. | - |
| 2013 | 16.8 mio. | -84 mio. | -68.5 mio. | 44.4 mio. | - |
Official annual report
How creditworthy is INBICON A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of October 9, 2015, Anna-Lena Elisabet Jeppsson is registered as director of INBICON A/S.
As of October 9, 2015, Henrik Maimann has stepped down as director of INBICON A/S.
INBICON A/S has published its annual report for 2014. Revenue came to DKK 13,979,000, and the net result was DKK -45,435,000.
About INBICON A/S
INBICON A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2003. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ELSAM BIOSYSTEMS A/S and KR 354 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. The company has 0 employees (2011). In 2025, the company reported a net result of DKK -3,447,000 compared with DKK 7,237,000 the year before. Equity in the 2025 report amounted to DKK 35,752,000.